Approval · Notice of Compliance 36825 · 2026
NEUPRO: Notice of Compliance 36825
Issued February 2, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36825
- Date
- February 2, 2026
- Company
- Ucb Canada IncOakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product Monograph reformatted to the Master Template.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NEUPRO | Not yet assigned | — |
Medicinal ingredients
- ROTIGOTINE 1 MG per PATCH
- ROTIGOTINE 2 MG per PATCH
- ROTIGOTINE 3 MG per PATCH
- ROTIGOTINE 4 MG per PATCH
- ROTIGOTINE 6 MG per PATCH
- ROTIGOTINE 8 MG per PATCH